ArticleActa pharmaceutica Sinica. B2022

SMIP-30, a potent and selective PPM1A inhibitor with potential to treat tuberculosis.

Shujing Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.